oral glp-1 medications FDA approves Foundayo, an alternative to Wegovy and Ozempic GLP-1 Agonists: A Comprehensive Overview

Gemigliptin and evogliptin were soon approved in Korea, and gosogliptin was approved in Russia

"Efficacy and tolerability of tirzepatide, a dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes: A 12-week, randomized, double-blind, placebo-controlled study to evaluate different dose-escalation regimens"

PMID 40291085

Most people have heard at least something about glucagon-like peptide 1 receptor agonists, more commonly known as GLP-1 medications, or GLP-1s

With these drugs, the main side effects are nausea, vomiting, constipation, diarrhea, and other gastrointestinal issues

GLP-1 possesses unique properties, including glucose-dependent insulin secretion, which confer a broad therapeutic index and reduce the risk of hypoglycemia